In This Article:
We recently published a list of 10 Firms Drenched in Red Today. In this article, we are going to take a look at where Oscar Health, Inc. (NYSE:OSCR) stands against other firms that are drenched in red today.
Ten companies pulled back on Wednesday, booking hefty losses during the trading session, with investor sentiment weighed down by a flurry of government policies and dismal earnings performance in the last quarter of the year.
Meanwhile, the Dow Jones fell by 1.91 percent, the S&P 500 declined by 1.61 percent, and the tech-heavy Nasdaq dropped 1.41 percent.
In this article, let us take a look at the 10 companies that led a poor performance during the day and explore the reasons behind their drop.
To come up with the list, we considered only the stocks with a $2 billion market capitalization and $5 million in trading volume.
A close up of a patient and a healthcare professional engaging in conversation, showing the company's commitment to patient care.
Oscar Health, Inc. (NYSE:OSCR)
Oscar Health saw its share prices decline for a third straight day on Wednesday, slashing 9.78 percent to end at $14.86 each as investors sold off positions following news that the Trump administration is ramping up audits of insurance firms offering Medicare Advantage.
On Wednesday, the Centers for Medicare and Medicaid Services said that it would employ an additional 2,000 encoders by September and use advanced technology systems to audit data and make sure diagnoses that claims from Medicare Advantage insurers are aligned with the patients’ medical records.
The agency said the initiative could claw back some $500 million a year for taxpayers.
This means that Oscar Health, Inc. (NYSE:OSCR) would be included in the review, being one of the insurance firms offering such services.
In other recent news, Oscar Health, Inc. (NYSE:OSCR) said it achieved a 55-percent increase in net income attributable to the company of $275 million versus the $177 million in the same period last year.
Revenues were also higher by 42 percent to $3.05 billion from $2.14 billion year-on-year.
Overall, OSCR ranks 3rd on our list of firms that are drenched in red today. While we acknowledge the potential of OSCR as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than OSCR but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.